Evolving medical treatment in advanced/recurrent endometrial cancer

Management of breast cancer recurrence

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS

Neo-adjuvant therapy and surgical decision making in breast cancer

Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer

ITACA NSCLC study: Final results

Renal liposarcoma: Case report and review of systemic treatment

Updates on managing HER2-positive early breast cancer

Managing HER2-positive breast cancer

Management of axilla after neo-adjuvant treatment

KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC

TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC